Phenotyping of Adaptive Immune Responses in Inflammatory Diseases

Immunophenotyping on the molecular and cellular level is a central aspect for characterization of patients with inflammatory diseases, both to better understand disease etiopathogenesis and based on this to develop diagnostic and prognostic biomarkers which allow patient stratification and tailor-ma...

Full description

Bibliographic Details
Main Authors: Jens Y. Humrich, Joana P. Bernardes, Ralf J. Ludwig, David Klatzmann, Alexander Scheffold
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-11-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2020.604464/full
id doaj-9c2e7f0d61bd446b8960bd6310295262
record_format Article
spelling doaj-9c2e7f0d61bd446b8960bd63102952622020-12-08T08:44:02ZengFrontiers Media S.A.Frontiers in Immunology1664-32242020-11-011110.3389/fimmu.2020.604464604464Phenotyping of Adaptive Immune Responses in Inflammatory DiseasesJens Y. Humrich0Joana P. Bernardes1Ralf J. Ludwig2David Klatzmann3Alexander Scheffold4Department of Rheumatology and Clinical Immunology, University Hospital Schleswig-Holstein—Campus Lübeck, Lübeck, GermanyInstitute of Clinical Molecular Biology, Christian-Albrechts-University Kiel, Kiel, GermanyLübeck Institute of Experimental Dermatology (LIED), University of Lübeck, Lübeck, GermanySorbonne Université, INSERM, Immunology-Immunopathology-Immunotherapy (i3), Paris, FranceInstitute of Immunology, Christian-Albrechts-University Kiel, Kiel, GermanyImmunophenotyping on the molecular and cellular level is a central aspect for characterization of patients with inflammatory diseases, both to better understand disease etiopathogenesis and based on this to develop diagnostic and prognostic biomarkers which allow patient stratification and tailor-made treatment strategies. Technology-driven developments have considerably expanded the range of analysis tools. Especially the analysis of adaptive immune responses, often regarded as central though mostly poorly characterized disease drivers, is a major focus of personalized medicine. The identification of the disease-relevant antigens and characterization of corresponding antigen-specific lymphocytes in individual patients benefits significantly from recent developments in cytometry by sequencing and proteomics. The aim of this workshop was to identify the important developments for state-of-the-art immunophenotyping for clinical application and precision medicine. We focused here on recent key developments in analysis of antigen-specific lymphocytes, sequencing, and proteomics approaches, their relevance in precision medicine and the discussion of the major challenges and opportunities for the future.https://www.frontiersin.org/articles/10.3389/fimmu.2020.604464/fullimmunophenotypingsequencingproteomicsinflammationprecision medicineTCR repertoire
collection DOAJ
language English
format Article
sources DOAJ
author Jens Y. Humrich
Joana P. Bernardes
Ralf J. Ludwig
David Klatzmann
Alexander Scheffold
spellingShingle Jens Y. Humrich
Joana P. Bernardes
Ralf J. Ludwig
David Klatzmann
Alexander Scheffold
Phenotyping of Adaptive Immune Responses in Inflammatory Diseases
Frontiers in Immunology
immunophenotyping
sequencing
proteomics
inflammation
precision medicine
TCR repertoire
author_facet Jens Y. Humrich
Joana P. Bernardes
Ralf J. Ludwig
David Klatzmann
Alexander Scheffold
author_sort Jens Y. Humrich
title Phenotyping of Adaptive Immune Responses in Inflammatory Diseases
title_short Phenotyping of Adaptive Immune Responses in Inflammatory Diseases
title_full Phenotyping of Adaptive Immune Responses in Inflammatory Diseases
title_fullStr Phenotyping of Adaptive Immune Responses in Inflammatory Diseases
title_full_unstemmed Phenotyping of Adaptive Immune Responses in Inflammatory Diseases
title_sort phenotyping of adaptive immune responses in inflammatory diseases
publisher Frontiers Media S.A.
series Frontiers in Immunology
issn 1664-3224
publishDate 2020-11-01
description Immunophenotyping on the molecular and cellular level is a central aspect for characterization of patients with inflammatory diseases, both to better understand disease etiopathogenesis and based on this to develop diagnostic and prognostic biomarkers which allow patient stratification and tailor-made treatment strategies. Technology-driven developments have considerably expanded the range of analysis tools. Especially the analysis of adaptive immune responses, often regarded as central though mostly poorly characterized disease drivers, is a major focus of personalized medicine. The identification of the disease-relevant antigens and characterization of corresponding antigen-specific lymphocytes in individual patients benefits significantly from recent developments in cytometry by sequencing and proteomics. The aim of this workshop was to identify the important developments for state-of-the-art immunophenotyping for clinical application and precision medicine. We focused here on recent key developments in analysis of antigen-specific lymphocytes, sequencing, and proteomics approaches, their relevance in precision medicine and the discussion of the major challenges and opportunities for the future.
topic immunophenotyping
sequencing
proteomics
inflammation
precision medicine
TCR repertoire
url https://www.frontiersin.org/articles/10.3389/fimmu.2020.604464/full
work_keys_str_mv AT jensyhumrich phenotypingofadaptiveimmuneresponsesininflammatorydiseases
AT joanapbernardes phenotypingofadaptiveimmuneresponsesininflammatorydiseases
AT ralfjludwig phenotypingofadaptiveimmuneresponsesininflammatorydiseases
AT davidklatzmann phenotypingofadaptiveimmuneresponsesininflammatorydiseases
AT alexanderscheffold phenotypingofadaptiveimmuneresponsesininflammatorydiseases
_version_ 1724390218310615040